Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Atypical Lipomatous Tumor with Structural Rearrangements Involving Chromosomes 3 and 8

JUN NISHIO, HIROSHI IWASAKI, KAZUKI NABESHIMA, YUKI KAMACHI and MASATOSHI NAITO
Anticancer Research June 2014, 34 (6) 3073-3076;
JUN NISHIO
1Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jnishio{at}cis.fukuoka-u.ac.jp
HIROSHI IWASAKI
2Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUKI NABESHIMA
2Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKI KAMACHI
1Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASATOSHI NAITO
1Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Atypical lipomatous tumor (ALT) is an intermediate (locally aggressive) mesenchymal neoplasm with the potential to dedifferentiate to higher grades over time. It is cytogenetically characterized by the presence of one or more supernumerary ring and giant marker chromosomes. These abnormal chromosomes invariably contain amplified sequences derived from the 12q14-15 region. We describe a unique cytogenetic finding of ALT arising in the right lower back of a 42-year-old man. Magnetic resonance imaging demonstrated a predominantly fatty mass with irregularly thickened, linear, swirled, and nodular septa. Contrast-enhanced fat-suppressed T1-weighted images showed significant enhancement of the non-adipose areas. A sub-extensive resection was performed. Histologically, the tumor consisted predominantly of mature fat cells with atypical stromal cells and multivacuolated lipoblasts. Immunohistochemically, the tumor cells were positive for p16 (diffuse and strong signal) and cyclin-dependent kinase-4 (focal and weak signal) but negative for murine double-minute 2. Cytogenetic analysis displayed a t(3;8)(q28;q13) translocation as the sole anomaly or concomitant with a few other numerical and structural alterations. There has been no evidence of local recurrence two months after surgery. To the best of our knowledge, this is the first case of ALT with structural aberrations involving chromosomes 3 and 8, associated with an absence of 12q rearrangements.

  • Atypical lipomatous tumor
  • cytogenetics
  • lipoma
  • p16
  • well-differentiated liposarcoma

Atypical lipomatous tumor (ALT) is a locally aggressive mesenchymal neoplasm composed either entirely or in part of a mature adipocytic proliferation exhibiting at least focal nuclear atypia in adipocytes or stromal cells. It occurs most frequently in the deep soft tissue of the limbs but may also arise in the subcutaneous tissue (1). ALT usually presents as a painless, slowly-growing mass that can attain a very large size. Three main histological subtypes of ALT are recognized: adipocytic (lipoma-like), sclerosing, and inflammatory (1). Immunostaining for p16, cyclin-dependent kinase-4 (CDK4), and murine double-minute-2 (MDM2) has recently been shown to be a highly sensitive and specific means of distinguishing ALTs from other adipocytic tumors (2). The cytogenetic hallmark of ALT is the presence of one or more supernumerary ring and giant marker chromosomes (3). These supernumerary chromosomes consistently contain amplified material from chromosome 12 (4). A few cases of ALT with other types of chromosomal aberrations have been reported (5, 6). In this article, we describe a unique cytogenetic finding of subcutaneous ALT occurring in the lower back of a middle-aged man.

Case Report

A 42-year-old man presented with a painless mass in the right lower back. The patient's past medical history was unremarkable. Physical examination revealed an 11-cm, soft, mobile, non-tender mass. Neurovascular examinations were unremarkable. Laboratory values were within normal ranges. Magnetic resonance imaging (MRI) showed a well-circumscribed, subcutaneous mass, measuring 11×7×3 cm. The mass exhibited predominant signal intensity of fat with multiple thick septa and several nonadipose areas of intermediate signal intensity on T1- and T2-weighted images (Figure 1A and B). Contrast-enhanced fat-suppressed T1-weighted images (Figure 1C) demonstrated significant enhancement of the nonadiposal areas. Based on these features, ALT was considered.

A sub-extensive resection was performed. Microscopically, the tumor was composed chiefly of mature fat cells with a variable number of atypical stromal cells and multivacuolated lipoblasts (Figure 2A and B). Immunohistochemically, the tumor cells were diffusely and strongly positive for p16 (Figure 2C) and focally and weakly for CDK4 (Figure 2D) but negative for MDM2. The histological findings were compatible with ALT.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Axial magnetic resonance images of atypical lipomatous tumor involving the right lower back. T1- (A) and T2- (B) weighted images exhibiting a largely lipomatous subcutaneous mass with prominent thick septa and several nonadipose areas. Contrast-enhanced fat-suppressed T1-weighted image (C) shows significant enhancement of the non-adiposal areas.

Cytogenetic analysis showed a reciprocal translocation involving the long arms of chromosomes 3 and 8 (Figure 3). The karyotype was as follows: 46,XY,t(3;8)(q28;q13)[1]/44,idem,-10,-13,add(16)(q11.2)[17]/46,XY[2].

The postoperative course was uneventful, and the patient is doing well without local recurrence two months after surgery.

Discussion

Cytogenetic analysis of adipocytic tumors has shown that the various histologic subtypes are characterized by distinctive clonal chromosomal aberrations (3). Ordinary lipomas typically display translocations involving the 12q13-15 region. The most frequent translocation is t(3;12)(q27-28;q13-15) (7). Lipoblastomas are characterized by 8q11-13 rearrangements (8). ALTs are characterized by the presence of one or more supernumerary ring and giant marker chromosomes (3-5). Fluorescence in situ hybridization and comparative genomic hybridization studies have shown that these supernumerary chromosomes always contain amplified sequences of the 12q14-15 region, including the CDK4 and MDM2 genes (4). A variety of other chromosomal regions, including 12q21-22 and 1q21-25 for the most frequently involved, have also been shown to be co-amplified in these supernumerary chromosomes (5).

In the present case, we did not identify any supernumerary ring or giant marker chromosomes containing 12q amplification or any other chromosome 12 rearrangements. Instead, we observed a t(3;8)(q28;q13) translocation as the sole anomaly or concomitant with a few other numerical and structural alterations. This reciprocal translocation is not usual in ALTs. Cytogenetic changes of 3q27-28 are found in a subset of ordinary lipomas. The lipoma preferred partner (LPP) gene, located at 3q28, plays a crucial role in the pathogenesis of ordinary lipomas (7). On the other hand, structural rearrangements of 8q11-13 are seen in almost all lipoblastomas (8). The pleomorphic adenoma gene 1 (PLAG1) gene, located at 8q12, is the target of the 8q rearrangements (7). Only one case of ALT with 8q11 rearrangement resulting in PLAG1 rearrangement has been described (9). Brandal et al. reported that the sensitivity of 8q11-13 rearrangements for diagnosing lipoblastomas when found in an adipocytic tumor was 77% and the corresponding specificity was 98% (9). Although the finding of 8q13 rearrangements had led to a revision of the diagnosis, the ALT diagnosis was histologically quite certain.

Deletions and structural rearrangements of chromosome 13 are frequently detected in adipocytic tumors, including ALT (10). In the present case, we observed monosomy 13. Dahlén et al. suggested that deletions of a limited segment within 13q14 may play an important role in the development of a subset of adipocytic tumors (10). Recent single nucleotide polymorphism array analyses have revealed that only the chromosome 13 open reading frame 1 (C13orf1) gene is significantly down-regulated in ordinary lipomas and spindle cell lipomas with 13q14 deletions (11).

p16/CDKN2A, located at 9p21, is a tumor-suppressor gene and encodes for a nuclear protein that can block cell-cycle progression by effectively inhibiting the kinase activity of CDK4/6. Although its precise role remains unknown, overexpression has been shown in ALT relative to normal fat (12). A recent study has shown that immunostaining for p16 is effective in distinguishing ALTs from ordinary lipomas, which do not overexpress this protein (13). More recently, Thway et al. reported that p16 was the most sensitive and specific marker for detecting ALT (2). In the present case, diffuse and strong nuclear staining for p16 was observed, strongly supporting a diagnosis of ALT. On the other hand, overexpression of MDM2 and CDK4 has also been indentified in ALTs (2, 14). The present case failed to show MDM2 immunopositivity and revealed very weak expression of CDK4. Generally, gene amplification is the main mechanism of overexpression of MDM2 and CDK4 in soft tissue tumors. We speculate that these findings may be correlated with the absence of any supernumerary ring and giant marker chromosomes containing 12q amplification.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Histological and immunohistochemical findings of atypical lipomatous tumor. A: The tumor consists predominantly of mature fat cells showing marked variation in cell size (H&E staining, original magnification ×40). B: Atypical, hyperchromatic stromal cells are also found (H&E staining, original magnification ×100). Immunohistochemically, the tumor cells are diffusely and strongly positive for p16 (C) and focally and weakly positive for CDK4 (D) (C and D, original magnification ×100).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

A representative G-banded karyotype of atypical lipomatous tumor displaying a t(3;8)(q28;q13) translocation (arrows).

In summary, we believe that we have described the first case of ALT with structural rearrangements involving chromosomes 3 and 8. The present case did not show any of the chromosomal features usually described in ALTs, such as supernumerary ring or giant marker chromosomes. Further studies are required to elucidate the role of this rare translocation in the pathogenesis of ALT.

Acknowledgements

This study was supported in part by the Foundation for the Promotion of Medical Science and JSPS KAKENHI Grant Number 25462355.

  • Received February 25, 2014.
  • Revision received April 29, 2014.
  • Accepted April 30, 2014.
  • Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Fletcher CDM,
    2. Bridge JA,
    3. Hogendoorn PCW,
    4. Mertens F
    1. Dei Tos AP,
    2. Pedeutour F
    : Atypical lipomatous tumour. In: World Health Organization Classification of Tumours of Soft Tissue and Bone. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (eds.). Lyon, IARC Press, pp. 33-36, 2013.
  2. ↵
    1. Thway K,
    2. Flora R,
    3. Shah C,
    4. Olmos D,
    5. Fisher C
    : Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol 36: 462-469, 2012.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Nishio J
    : Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors. J Biomed Biotechnol 2011: 524067, 2011.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Pedeutour F,
    2. Forus A,
    3. Coindre JM,
    4. Berner JM,
    5. Nicolo G,
    6. Michiels JF,
    7. Terrier P,
    8. Ranchere-Vince D,
    9. Collin F,
    10. Myklebost O,
    11. Turc-Carel C
    : Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24: 30-41, 1999.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Sandberg AA
    : Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet 155: 1-24, 2004.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Nilsson M,
    2. Domanski H,
    3. Mertens F,
    4. Mandahl N
    : Atypical lipomatous tumor with rare structural rearrangements involving chromosomes 8 and 12. Oncol Rep 13: 649-652, 2005.
    OpenUrlPubMed
  7. ↵
    1. Sandberg AA
    : Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: lipoma. Cancer Genet Cytogenet 150: 93-115, 2004.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Bartuma H,
    2. Domanski HA,
    3. Von Steyern FV,
    4. Kullendorff CM,
    5. Mandahl N,
    6. Mertens F
    : Cytogenetic and molecular cytogenetic findings in lipoblastoma. Cancer Genet Cytogenet 183: 60-63, 2008.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Brandal P,
    2. Bjerkehagen B,
    3. Heim S
    : Rearrangement of chromosomal region 8q11-13 in lipomatous tumours: correlation with lipoblastoma morphology. J Pathol 208: 388-394, 2006.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Dahlén A,
    2. Debiec-Rychter M,
    3. Pedeutour F,
    4. Domanski HA,
    5. Höglund M,
    6. Bauer HC,
    7. Rydholm A,
    8. Sciot R,
    9. Mandahl N,
    10. Mertens F
    : Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 103: 616-623, 2003.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Bartuma H,
    2. Nord KH,
    3. Macchia G,
    4. Isaksson M,
    5. Nilsson J,
    6. Domanski HA,
    7. Mandahl N,
    8. Mertens F
    : Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion. Genes Chromosomes Cancer 50: 619-632, 2011.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Singer S,
    2. Socci ND,
    3. Ambrosini G,
    4. Sambol E,
    5. Decarolis P,
    6. Wu Y,
    7. O'Connor R,
    8. Maki R,
    9. Viale A,
    10. Sander C,
    11. Schwartz GK,
    12. Antonescu CR
    : Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67: 6626-6636, 2007.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. He M,
    2. Aisner S,
    3. Benevenia J,
    4. Patterson F,
    5. Aviv H,
    6. Hameed M
    : p16 immunohistochemistry as an alternative marker to distinguish atypical lipomatous tumor from deep-seated lipoma. Appl Immunohistochem Mol Morphol 17: 51-56, 2009.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Binh MB,
    2. Sastre-Garau X,
    3. Guillou L,
    4. de Pinieux G,
    5. Terrier P,
    6. Lagacé R,
    7. Aurias A,
    8. Hostein I,
    9. Coindre JM
    : MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 29: 1340-1347, 2005.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 34, Issue 6
June 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Atypical Lipomatous Tumor with Structural Rearrangements Involving Chromosomes 3 and 8
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
17 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Atypical Lipomatous Tumor with Structural Rearrangements Involving Chromosomes 3 and 8
JUN NISHIO, HIROSHI IWASAKI, KAZUKI NABESHIMA, YUKI KAMACHI, MASATOSHI NAITO
Anticancer Research Jun 2014, 34 (6) 3073-3076;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Atypical Lipomatous Tumor with Structural Rearrangements Involving Chromosomes 3 and 8
JUN NISHIO, HIROSHI IWASAKI, KAZUKI NABESHIMA, YUKI KAMACHI, MASATOSHI NAITO
Anticancer Research Jun 2014, 34 (6) 3073-3076;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors
  • Google Scholar

More in this TOC Section

  • The Prognostic Impact of Perioperative Inflammatory Status in Elderly Patients With Gastric Cancer
  • Preoperative Serum Total Cholesterol Predicts Adjuvant Chemotherapy Completion After Pancreaticoduodenectomy for Pancreatic Cancer
  • Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer
Show more Clinical Studies

Keywords

  • Atypical lipomatous tumor
  • cytogenetics
  • lipoma
  • p16
  • well-differentiated liposarcoma
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire